Allan Saul1. 1. Laboratory of Malaria and Vector Biology, NIAID, NIH, Rockville, Maryland 20852, USA. ASaul@niaid.nih.gov
Abstract
PURPOSE OF REVIEW: This review highlights progress made in the development of vaccines aimed at the stages of malaria parasites found in mosquitoes that block the transmission of malaria within a community. RECENT FINDINGS: Substantial progress has been made on the production and characterization of the leading candidates P25 and P28 from Plasmodium falciparum and P. vivax. Immunogenicity data have been obtained for P25 in humans that showed significant transmission blocking activity and further advances in formulation should boost this activity. The completion of the malaria genome and ongoing proteomics identified further candidate antigens now entering development. SUMMARY: Recent advances increase confidence that a mosquito stage transmission blocking malaria vaccine will be feasible.
PURPOSE OF REVIEW: This review highlights progress made in the development of vaccines aimed at the stages of malaria parasites found in mosquitoes that block the transmission of malaria within a community. RECENT FINDINGS: Substantial progress has been made on the production and characterization of the leading candidates P25 and P28 from Plasmodium falciparum and P. vivax. Immunogenicity data have been obtained for P25 in humans that showed significant transmission blocking activity and further advances in formulation should boost this activity. The completion of the malaria genome and ongoing proteomics identified further candidate antigens now entering development. SUMMARY: Recent advances increase confidence that a mosquito stage transmission blocking malaria vaccine will be feasible.
Authors: Viengngeun Bounkeua; Fengwu Li; Raul Chuquiyauri; Shira R Abeles; Colleen M McClean; Victor Neyra; Alejandro Llanos-Cuentas; Pablo P Yori; Joseph M Vinetz Journal: Am J Trop Med Hyg Date: 2011-08 Impact factor: 2.345
Authors: Feng Qian; Joan A Aebig; Karine Reiter; Emma Barnafo; Yanling Zhang; Richard L Shimp; Kelly M Rausch; David S Jones; Daming Zhu; Lynn Lambert; Gregory E D Mullen; David L Narum; Louis H Miller; Yimin Wu Journal: Microbes Infect Date: 2008-12-27 Impact factor: 2.700
Authors: Fengwu Li; Kailash P Patra; Charles A Yowell; John B Dame; Karen Chin; Joseph M Vinetz Journal: J Biol Chem Date: 2010-01-07 Impact factor: 5.157
Authors: Thomas S Churcher; Emma J Dawes; Robert E Sinden; George K Christophides; Jacob C Koella; María-Gloria Basáñez Journal: Malar J Date: 2010-11-04 Impact factor: 2.979
Authors: Jacob E Crawford; Susan M Rottschaefer; Boubacar Coulibaly; Madjou Sacko; Oumou Niaré; Michelle M Riehle; Sékou F Traore; Kenneth D Vernick; Brian P Lazzaro Journal: Infect Genet Evol Date: 2013-01-26 Impact factor: 3.342